Community Academic Profiles–

Gerald Reaven, MD

Back to Profile

Publication Details

  • ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk.

    Ardigo D, Stüehlinger M, Franzini L, Valtueña S, Piatti PM, Pachinger O, Reaven GM, Zavaroni I. Eur J Clin Invest. 2007; 37 (4): 263-9

    Increased plasma concentrations of asymmetric dimethylarginine (ADMA) contribute to impair endothelial function in patients with established cardiovascular disease (CVD) and/or individuals with clinical syndromes known to increase CVD. However, the impact of ADMA on endothelial function in apparently healthy individuals has not been determined.

    PubMedID: 17373961

Stanford Medicine Resources:

Footer Links: